Innovative Medical Technology Firm, Sky Medical, Honors with King's award for ingenious enterprisegeko device innovation
The Geko device, a groundbreaking neuromuscular electrostimulation technology, is making waves in the global healthcare industry. This device, developed by Sky Medical Technology Ltd, a UK-based medical device innovator, has been recognised for its significant impact on chronic wound healing.
The Geko device has shown impressive results in improving blood flow in patients with chronic wounds, promoting faster healing and reduction of edema. According to a pivotal randomised self-controlled trial (RCT), the device increases wound healing rates to about 0.56 mm per week compared to 0.31 mm in control groups[1]. This represents a clear advantage in healing efficacy.
The device works by activating the muscle pump in the lower extremity, enhancing circulation, which is critical for wound recovery[5]. It is gaining traction as part of modern wound care practices, with clinicians increasingly deploying it alongside traditional compression therapy, particularly for hard-to-heal venous leg ulcers (VLUs).
The Geko device is being rapidly adopted across multiple NHS primary care clinics and is designed for ease of use in both clinical and home settings, allowing patients to manage their care more independently.
Sky Medical Technology has been awarded the King's Award for Enterprise in Innovation for its breakthrough wound care technology, the Geko device. This prestigious award, given to the UK's most forward-thinking and high-performing businesses, was presented to only 197 organisations this year[6].
Fiona Young, Firstkind Wound Therapy Business Director, commented that the Geko device delivers real-world value clinically, operationally, and economically[4].
With FDA clearance, NICE guidance, and integration across NHS Trusts and international health systems, the company claims the Geko device is establishing a new standard in chronic wound management. The device's proprietary neuromuscular electrostimulation technology increases lower limb blood flow, accelerating healing and recovery.
Chronic wounds remain a critical global health challenge, costing healthcare systems billions annually. The Geko device addresses this unmet need with a clinically validated, non-invasive therapy. Clinicians are engaging patients and keeping them on protocol with the rapid effect on healing seen with the use of the Geko device.
Patient-reported benefits are drawing attention in clinical settings with the use of the Geko device. Q1 sales results for the device are over budget, and the number of prescriptions for the Geko device is increasing by over 60% quarter-over-quarter for the last 3 consecutive quarters.
The Geko device's global recognition is evident in its showcasing at professional events such as WoundWISE, a Canadian educational series for healthcare professionals, highlighting its practical applications and benefits[2][5]. Its increasing acceptance internationally, particularly in markets where chronic wounds represent a growing burden due to aging populations and diabetes prevalence, is a testament to its transformative potential.
In summary, the Geko device currently represents a clinically validated, impactful innovation in chronic wound healing worldwide, improving healing rates through enhanced circulation and gaining momentum in healthcare systems via targeted education and adoption efforts[1][2][5].
- The Geko device, a medical-condition oriented innovation by Sky Medical Technology Ltd, is changing the landscape of healthcare with its neuromuscular electrostimulation technology, specifically impacting patient care in chronic wound healing.
- The device's innovative technology is being recognized in both science and health-and-wellness sectors, showcasing its potential in the medical-plastics industry and fostering advancements in health-related technology.
- As the Geko device demonstrates improved healing rates and reduced edema in patients with chronic wounds, it's gaining traction in modern-day treatment practices, signifying a new standard for health-and-wellness and medical-conditions management.
